Shares of SenesTech SNES decreased in after-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share increased 87.36% over the past year to ($0.22), which missed the estimate of ($0.16).
Revenue of $88,000 higher by 137.84% year over year, which beat the estimate of $80,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
SenesTech hasn't issued any revenue guidance for the time being.
How To Listen To The Conference Call
Date: May 13, 2021
Time: 05:00 PM
ET Webcast URL: https://www.webcaster4.com/Webcast/Page/1621/40890
Technicals
52-week high: $3.36
Company's 52-week low was at $1.30
Price action over last quarter: down 20.79%
Company Profile
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
